Calidi Biotherapeutics

Calidi Biotherapeutics is a clinical-stage biotechnology company dedicated to developing innovative immunotherapies for the treatment of cancer. They specialize in the development of "off-the-shelf" stem cell-based platforms that deliver oncolytic viruses directly to tumors. These platforms are designed to kill cancer cells locally and then activate the immune system to target remaining cancer cells throughout the body, potentially preventing metastatic disease. Calidi's technology has shown promising results in preclinical and clinical trials, and they have a robust pipeline of product candidates in various stages of development.

Based in San Diego, California, Calidi Biotherapeutics boasts a seasoned team of executives, scientists, and physicians. The company has secured significant investments and partnerships, including licensing agreements with pharmaceutical companies and research collaborations with leading academic institutions like Northwestern University and City of Hope. Calidi is actively pursuing clinical trials for its promising therapies and is committed to bringing cutting-edge cancer treatments to market.

Calidi Biotherapeutics is a clinical-stage biotechnology company dedicated to developing innovative immunotherapies for solid tumors. Their mission is to redefine cancer treatment by creating a world free from the threat of cancer. Calidi's "off-the-shelf" stem cells, engineered to deliver a viral payload, target cancer cells locally and activate the immune system to combat metastatic disease. Through rigorous research and a commitment to pioneering breakthroughs, Calidi is advancing a robust pipeline of next-generation therapies designed to treat and potentially prevent the spread of cancer.

Calidi Biotherapeutics promotes a culture of innovation and collaboration, driven by a shared passion for developing groundbreaking cancer treatments. They foster a team environment comprised of experts and innovators who are dedicated to redefining cancer treatment. Their commitment to cutting-edge research and the pursuit of a world free from cancer is reflected in their workplace, where collaboration, scientific excellence, and a strong sense of purpose are valued and encouraged.

Calidi Biotherapeutics is committed to fostering a diverse, equitable, and inclusive workplace. Their Chief Legal Officer and Chief Diversity Officer, Wendy Pizarro, spearheads initiatives to shape both internal and external policies, ensuring that DEI principles are integrated into recruitment, marketing, and the company's strategic plan. Their commitment to DEI is reflected in their diverse leadership team and their dedication to creating a welcoming and equitable environment for all employees.